London School of Hygiene and Tropical Medicine has signed a deal with LifeArc for the charity to provide a range of technology transfer services to the institution.
UK-based medical research charity LifeArc has inked an agreement with London School of Hygiene and Tropical Medicine (LSHTM) to support the institution’s tech transfer activities.
Financial terms of the agreement have not been revealed.
LifeArc was founded in 1999 as MRC Technology, bringing together different units of the Medical Research Council. The council is a UK government agency responsible for coordinating and funding medical research, and is one of seven such agencies in the country.
The charity funds academic and early-stage research in the life sciences sector. It already provides technology transfer services to the Medical Research Council and various charities and non-profit organisations.
LifeArc also operates laboratories in Stevenage, where researchers focus on antibody and small molecules, and Edinburgh, where researchers focus on diagnostics development.
London School of Hygiene & Tropical Medicine is a constituent college of University of London. The institution has three faculties – Epidemiology and Population Health, Infectious and Tropical Diseases, and Public Health and Policy.
The school currently has more than 1,000 staff located in more than 100 countries, teaching more than 4,000 students.
Peter Piot, director of London School of Hygiene and Tropical Medicine, said: “The world is facing unprecedented challenges in the form of infectious and chronic conditions, and emerging health threats.
“We need to innovate to meet these challenges and improve health for all. This exciting partnership with LifeArc will intensify efforts to translate our research in ways that have a tangible impact.”
Andrew Farquharson, executive director for technology transfer at LifeArc, said: “LifeArc exists to make a difference for patients and to achieve this we have to make sure that promising medical research is progressed.
“London School of Hygiene and Tropical Medicine shares our aim of addressing major public and global health challenges, and we look forward to providing the expertise to help them maximise their research portfolio.”
